scholarly journals Soft-Tissue Response in Orthognathic Surgery Patients Treated by Bimaxillary Osteotomy. Cephalometry Compared with 2-D Photogrammetry

10.5772/51416 ◽  
2013 ◽  
Author(s):  
Jan Rustemeyer
Keyword(s):  
Soft Tissue ◽  
Orthognathic Surgery ◽  
Tissue Response ◽  
Soft Tissue Response

Soft tissue response and facial symmetry after orthognathic surgery

2014 ◽  
Vol 42 (6) ◽  
pp. e339-e345 ◽  
Author(s):  
Kai Wermker ◽  
Johannes Kleinheinz ◽  
Susanne Jung ◽  
Dieter Dirksen
Keyword(s):  
Soft Tissue ◽  
Orthognathic Surgery ◽  
Tissue Response ◽  
Facial Symmetry ◽  
Soft Tissue Response

Soft Tissue Response to Orthognathic Surgery in Persons with Unilateral Cleft Lip and Palate

1993 ◽  
Vol 30 (3) ◽  
pp. 320-327 ◽  
Author(s):  
Mark Ewing ◽  
R. Bruce Ross
Keyword(s):  
Soft Tissue ◽  
Orthognathic Surgery ◽  
Cleft Lip ◽  
Cleft Lip And Palate ◽  
Tissue Response ◽  
Appreciable Effect ◽  
Upper Lip ◽  
Anterior Maxilla ◽  
Maxillary Advancement ◽  
Soft Tissue Response

Individuals with cleft lip and palate often require Orthognathic surgery to establish facial harmony and optimal occlusal function. Surgery to the skeletal components of the face can accomplish predictable alterations in jaw relations. The soft tissue response to those skeletal movements, however, is difficult to predict, as it is also for the noncIeft individual. In addition there is the variability of the repaired cleft lip. The study included 30 persons with complete unilateral cleft lip and palate, operated for midface deficiency using a Le Fort I maxillary advancement at a mean age of 18.0 years. Some relapse occurred in the immediate postoperative period, but after 1 year the mean advancement of the maxilla was 4.9 mm (best fit of anterior maxilla) and 5.6 mm (incisai edge). Both skeletal and soft tissue changes were negligible after that time. The ratio of upper lip advancement to underlying incisor advancement was 0.65 to 1. Although the lip response was highly correlated to the underlying bony movement, the variation was sufficient to preclude accurate prediction. The upper lip thinned with maxillary advancement, but this was not related to the original lip thickness. Coincident mandibular surgery had no appreciable effect on upper lip movement.

Comparing the Responses of Osseous Versus Soft-Tissue Metastases of Renal Cell Carcinoma to Receptor Tyrosine Kinase Inhibitors and Immunotherapy

Kidney Cancer ◽  
2020 ◽  
Vol 4 (3) ◽  
pp. 151-158
Author(s):  
Katherine Yuxi Tai ◽  
Jad M. El Abiad ◽  
Carol D. Morris ◽  
Mark Christopher Markowski ◽  
Adam S. Levin
Keyword(s):  
Renal Cell Carcinoma ◽  
Soft Tissue ◽  
Cell Carcinoma ◽  
Receptor Tyrosine Kinase ◽  
Renal Cell ◽  
Kinase Inhibitors ◽  
Tissue Response ◽  
Bone Response ◽  
Soft Tissue Response ◽  
Receptor Tyrosine Kinase Inhibitors

BACKGROUND: Checkpoint inhibitors and receptor tyrosine kinase inhibitors (RTKIs) have changed the standard of care for metastatic renal cell carcinoma (mRCC). Anecdotal evidence suggests these therapies may be less effective for treating bone than soft-tissue metastases. PURPOSE: We performed a retrospective review evaluating the relative clinical responses in soft-tissue and bone metastases in patients undergoing therapy using RTKIs and anti-programmed death-1 (PD-1) agents for mRCC. METHODS: Of the 2,212 patients in our institutional cancer registry with renal cell carcinoma (1997–2017), 68 (82 disease courses) were identified with measurable bone and soft-tissue metastases treated with RTKIs and/or PD-1s. Extent of metastasis was quantified at the time of therapy initiation (baseline) and at 3 months, 6 months, and 1 year. Changes in disease status were categorized as complete response, partial response, stable, mixed, or progression of disease according to RECIST v1.1 and MD Anderson criteria. These categories were further organized into “response to treatment” or “evidence of progression” to generate a generalized linear effects model with soft-tissue response as the independent variable and bone response as the dependent variable. Alpha = 0.05. RESULTS: Soft-tissue response correlated with bone response at 3 months (76 disease courses, p = 0.005) and 6 months (48 disease courses, p = 0.017). Of the patients with controlled soft-tissue disease, only 14 (19%) and 15 (32%) had progression in bone at 3 and 6 months, respectively. CONCLUSION: Contrary to anecdotal reports, osseous metastases do not appear to respond worse than soft-tissue metastases to treatment with these agents.

Soft Tissue Response After Chin Advancement Using Two Different Genioplasty Techniques

2014 ◽  
Vol 25 (4) ◽  
pp. 1383-1388 ◽  
Author(s):  
Sameh Ahemd Seifeldin ◽  
Maha Shawky ◽  
Saleem M. Hicham Nouman
Keyword(s):  
Soft Tissue ◽  
Tissue Response ◽  
Soft Tissue Response
Sign in / Sign up

Export Citation Format

Share Document